Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3447738 | 0.90 | — | — | |
| SCHEMBL2903615 | 0.90 | — | — | |
| SCHEMBL3447932 | 0.89 | ALDH1A1 (0.31) | ALDH1A1 | |
| Nitrous Acid SCHEMBL3446898 | 0.87 | — | — | |
| SCHEMBL3448373 | 0.85 | — | — | |
| SCHEMBL3447736 | 0.84 | — | — | |
| SCHEMBL3447304 | 0.83 | ALDH1A1 (0.32) | ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL907487 | 0.81 | CES2 (0.36) | — | |
| SCHEMBL3448708 | 0.79 | — | — | |
| SCHEMBL3448903 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7854854-B2 | Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device | OTSUKA CHEMICAL CO., LTD. (JP) | 2010-12-21 | — | — | US | disclosed |
| US-20100038578-A1 | Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device | ALLY BANK, AS AGENT | 2010-02-18 | — | — | US | disclosed |
| EP-1840124-A1 | QUATERNARY AMMONIUM SALT, ELECTROLYTE, ELECTROLYTE SOLUTION AND ELECTROCHEMICAL DEVICE | Otsuka Chemical Co., Ltd. (JP) | 2007-10-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100038578-A1 | Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device | SCN1B, SCN1A, SCN11A | ALDH1A1 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.